|
Volumn 48, Issue 39, 2001, Pages 875-878
|
Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer
a a a a a a a a
a
HÔPITAL TENON
(France)
|
Author keywords
Advanced pancreatic cancer; Palliative chemotherapy
|
Indexed keywords
CISPLATIN;
FLUOROURACIL;
FOLINIC ACID;
GRANISETRON;
METOCLOPRAMIDE;
ONDANSETRON;
ADULT;
AGED;
ARTICLE;
BOLUS INJECTION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFECT;
DRUG INDUCED DISEASE;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
INFUSION;
MALE;
MULTICENTER STUDY;
PALLIATIVE THERAPY;
PANCREAS ADENOCARCINOMA;
PANCREAS CANCER;
PANCREAS SURGERY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TOXICITY;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PALLIATIVE CARE;
PANCREATIC NEOPLASMS;
PROSPECTIVE STUDIES;
|
EID: 0034935502
PISSN: 01726390
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (27)
|
References (28)
|